You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer
|
|---|---|
| Published in |
Molecular Cancer, February 2022
|
| DOI | 10.1186/s12943-022-01515-x |
| Pubmed ID | |
| Authors |
Lanxiang Huang, Yuan Rong, Xuan Tang, Kezhen Yi, Peng Qi, Jinxuan Hou, Weihuang Liu, Yuan He, Xing Gao, Chunhui Yuan, Fubing Wang |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 40% |
| India | 1 | 20% |
| Unknown | 2 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 60% |
| Science communicators (journalists, bloggers, editors) | 1 | 20% |
| Scientists | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 95 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 10 | 11% |
| Researcher | 8 | 8% |
| Student > Ph. D. Student | 6 | 6% |
| Student > Bachelor | 4 | 4% |
| Student > Doctoral Student | 2 | 2% |
| Other | 8 | 8% |
| Unknown | 57 | 60% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 11 | 12% |
| Medicine and Dentistry | 5 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
| Agricultural and Biological Sciences | 4 | 4% |
| Immunology and Microbiology | 3 | 3% |
| Other | 10 | 11% |
| Unknown | 57 | 60% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 February 2022.
All research outputs
#13,373,196
of 23,577,654 outputs
Outputs from Molecular Cancer
#825
of 1,782 outputs
Outputs of similar age
#203,733
of 521,269 outputs
Outputs of similar age from Molecular Cancer
#31
of 72 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,782 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 521,269 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 72 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.